Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RDHL

RedHill Biopharma

$6.20

0.07 (1.14%)

06:07
10/18/19
10/18
06:07
10/18/19
06:07
Hot Stocks
RedHill Biopharma receives $36M investment from Cosmo, signs license agreement »

RedHill Biopharma has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

Over a week ago
RDHL

RedHill Biopharma

$6.50

-0.26 (-3.85%)

09:04
10/11/19
10/11
09:04
10/11/19
09:04
Hot Stocks
RedHill Biopharma reports results from MAP US Phase 3 study of RHB-104 »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

RDHL

RedHill Biopharma

$6.76

0.1 (1.50%)

, TGIFF

1933 Industries

$0.00

(0.00%)

09:06
10/10/19
10/10
09:06
10/10/19
09:06
Conference/Events
PR Newswire to hold a virtual conference »

Virtual Investor…

RDHL

RedHill Biopharma

$6.76

0.1 (1.50%)

TGIFF

1933 Industries

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 02

    Nov

RDHL

RedHill Biopharma

$7.32

-0.1 (-1.35%)

08:31
09/26/19
09/26
08:31
09/26/19
08:31
Hot Stocks
RedHill Biopharma expects to enroll full cohort for Yeliva study by year-end »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

RDHL

RedHill Biopharma

$7.32

-0.1 (-1.35%)

08:29
09/26/19
09/26
08:29
09/26/19
08:29
Hot Stocks
RedHill Biopharma advancing toward Phase 3 study to support NDA for Bekinda »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

RDHL

RedHill Biopharma

$7.32

-0.1 (-1.35%)

08:28
09/26/19
09/26
08:28
09/26/19
08:28
Hot Stocks
RedHill Biopharma sees additional FDA guidance on RHB-104 path in coming months »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

RDHL

RedHill Biopharma

$7.32

-0.1 (-1.35%)

08:26
09/26/19
09/26
08:26
09/26/19
08:26
Hot Stocks
RedHill Biopharma plans to initiate Phase 3 study activities with RHB-204 in Q4 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

RDHL

RedHill Biopharma

$7.32

-0.1 (-1.35%)

08:25
09/26/19
09/26
08:25
09/26/19
08:25
Hot Stocks
RedHill Biopharma says NDA for RHB-105 under priority review by FDA »

The New Drug Application…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

Over a month ago
RDHL

RedHill Biopharma

$6.90

(0.00%)

07:17
08/21/19
08/21
07:17
08/21/19
07:17
Hot Stocks
RedHill Biopharma announces acceptance of oral presentations on RHB-105 »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:41
07/23/19
07/23
07:41
07/23/19
07:41
Hot Stocks
RedHill Biopharma continues to enroll patients in Phase 2a study of YELIVA »

The ongoing Phase 2a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.